Cited by 741Migraine and Headache StudiesHealth Systems, Economic Evaluations, Quality of LifeTemporomandibular Joint Disorders

The cost of headache disorders in Europe: the Eurolight project

Linde, M., Gustavsson, A., Stovner, L. J., Steiner, T. J., Barré, J., Katsarava, Z., Lainez, J. M., Lampl, C. +5 more·2012·European Journal of Neurology

Abstract

Background and purpose: Headache disorders are very common, but their monetary costs in Europe are unknown. We performed the first comprehensive estimation of how economic resources are lost to headache in Europe. Methods: From November 2008 to August 2009, a cross‐sectional survey was conducted in eight countries representing 55% of the adult EU population. Participation rates varied between 11% and 59%. In total, 8412 questionnaires contributed to this analysis. Using bottom‐up methodology, we estimated direct (medications, outpatient health care, hospitalization and investigations) and indirect (work absenteeism and reduced productivity at work) annual per‐person costs. Prevalence data, simultaneously collected and, for migraine, also derived from a systematic review, were used to impute national costs. Results: Mean per‐person annual costs were €1222 for migraine (95% CI 1055–1389; indirect costs 93%), €303 for tension‐type headache (TTH, 95% CI 230–376; indirect costs 92%), €3561 for medication‐overuse headache (MOH, 95% CI 2487–4635; indirect costs 92%), and €253 for other headaches (95% CI 99–407; indirect costs 82%). In the EU, the total annual cost of headache amongst adults aged 18–65 years was calculated, according to our prevalence estimates, at €173 billion, apportioned to migraine (€111 billion; 64%), TTH (€21 billion; 12%), MOH (€37 billion; 21%) and other headaches (€3 billion; 2%). Using the 15% systematic review prevalence of migraine, calculated costs were somewhat lower (migraine €50 billion, all headache €112 billion annually). Conclusions: Headache disorders are prominent health‐related drivers of immense economic losses for the EU. This has immediate implications for healthcare policy. Health care for headache can be both improved and cost saving.

Integrity signals

Registry

Crossref · 10.1111/j.1468-1331.2011.03612.x

Cites

32 of 32 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The financial implications of lost time show a clear gradient at personal level of probable MOH > migraine > TTH.

    “The inescapable financial implications of such losses, reported in detail elsewhere [19], again show a clear gradient at personal level of probable MOH > migraine > TTH.”
  • The level of this impact, and its pervasiveness, taken together with estimates of huge financial cost, have important implications for health policy in Europe.

    “The level of this impact, and its pervasiveness, taken together with estimates of huge financial cost [19], have important implications for health policy in Europe, since they are indicators not only of much public ill-health and unmet health-care need but also of high but reducible socioeconomic burden.”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Linde, M., Gustavsson, A., Stovner, L. J., Steiner, T. J., Barré, J., Katsarava, Z., Lainez, J. M., Lampl, C., Lantéri‐Minet, M., Rastenyte, D., Ruiz de la Torre, E., Tassorelli, C., & Andrée, C.
Affiliations
  • Norwegian University of Science and Technology (NO)
  • Centre de Recherche Public de la Santé (LU)
  • Essen University Hospital (DE)
  • Convent Hospital of the Brothers of Saint John of God (AT)
  • Centre Hospitalier Universitaire de Nice (FR)
  • University of Pavia (IT)
  • University of Basel (CH)
Corresponding author
Linde, M.
Venue
European Journal of Neurology
Publisher
Wiley
Published
2011-12-05
Volume
19
Issue
5
Pages
703-711
ISSN
  • 1351-5101 (ISSN-L)
  • 1468-1331
OpenAlex
W1793427412
Cited by
741
References
32
Citations by year
2026: 28 · 2025: 50 · 2024: 82 · 2023: 49 · 2022: 59 · 2021: 68 · 2020: 69 · 2019: 74 · 2018: 45 · 2017: 43 · 2016: 40 · 2015: 37 · 2014: 41 · 2013: 43 · 2012: 12
FWCI
21.22
Type
journal article
Language
en
Open access
closed
Locations
  • European Journal of Neurology (publishedVersion)
  • PubMed (publishedVersion)
  • Lithuanian University of Health Sciences (acceptedVersion)
  • Universitätsbibliographie, Universität Duisburg-Essen (submittedVersion)
  • Lithuanian University of Health Sciences (submittedVersion)
Topics
  • Health Sciences › Medicine › Psychiatry and Mental health › Migraine and Headache Studies
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
  • Health Sciences › Health Professions › Complementary and Manual Therapy › Temporomandibular Joint Disorders
Keywords
headache disorders, economic burden, migraine, tension-type headache, medication overuse headache, absenteeism, productivity loss, direct medical costs, indirect costs, prevalence, cost estimation, Europe
MeSH terms
Adolescent, Adult, Aged, Costs and Cost Analysis, Cross-Sectional Studies, Europe, Female, Health Surveys, Humans, Male, Middle Aged, Prevalence, Health Care Costs, Cost of Illness, Headache Disorders, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review